| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/28/2010 | EP1480650B1 Novel crystalline forms of the anti-cancer compound zd1839 |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | CN1553906B VARIOLIN derivatives and their use as antitumor agents |
| 04/28/2010 | CN101698663A N-substituted uracil phenylurea compounds for weeding |
| 04/28/2010 | CN101698662A Artificial synthesis method of 1,4,5,6-tetrahydro-2-methyl-4-pyrimidine carboxylic acid |
| 04/27/2010 | USRE41289 Ultrashort acting hypnotic barbiturates |
| 04/27/2010 | US7705148 substituted diaminopyrimidine compounds having HIV inhibiting properties; reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate (4-cyano, 2-pyrimidine- aniline derivative; reaction with acrylonitril |
| 04/27/2010 | US7705147 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 04/27/2010 | US7705145 reduction of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile to give 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile, hydration of intermediated to form 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide; cyclization |
| 04/27/2010 | US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils |
| 04/27/2010 | US7705009 4-aminopyrimidine-5-thione derivatives |
| 04/27/2010 | US7705008 Prostaglandin analogs |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
| 04/27/2010 | US7704996 Compounds and compositions useful as cathepsin S inhibitors |
| 04/27/2010 | US7704971 Uracil reductase inactivators |
| 04/27/2010 | CA2495880C Pyrimidine derivatives and their use as cb2 modulators |
| 04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/27/2010 | CA2293018C Optically active uracil compounds |
| 04/22/2010 | WO2010045379A2 Pyridine non-classical cannabinoid compounds and related methods of use |
| 04/22/2010 | WO2010045377A2 Pyrimidine non-classical cannabinoid compounds and related methods of use |
| 04/22/2010 | WO2010045374A1 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors |
| 04/22/2010 | WO2010044215A1 Optically active difluoromethanesulfonanilide derivative and herbicide |
| 04/22/2010 | WO2010044054A1 Phenethylamide derivatives and their heterocyclic analogues |
| 04/22/2010 | WO2010012442A3 Insecticidal benzenedicarboxamide derivative |
| 04/22/2010 | WO2009095773A3 Novel heterocycles |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099684 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands |
| 04/22/2010 | US20100099670 Benzoquinazoline derivatives |
| 04/22/2010 | US20100099658 Di(arylamino)aryl compound |
| 04/22/2010 | US20100098650 Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures |
| 04/22/2010 | DE102008052013A1 New 4-(4-cyano-2-thioaryl)dihydropyrimidinone compounds are neutrophil elastase inhibitors useful to treat or prevent e.g. pulmonary arterial hypertension, chronic obstructive pulmonary disease, acute lung injury, or cystic fibrosis |
| 04/22/2010 | CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues |
| 04/21/2010 | EP2177512A1 Inhibitor of binding of s1p1 |
| 04/21/2010 | EP2176241A2 A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b |
| 04/21/2010 | EP2176240A1 Amine salts of a crth2 antagonist |
| 04/21/2010 | EP2176239A1 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
| 04/21/2010 | EP2176238A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 04/21/2010 | EP2176222A1 Novel herbicides |
| 04/21/2010 | EP2175857A2 Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 04/21/2010 | EP2041093B1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 04/21/2010 | EP1610780B1 Cyclic protein tyrosine kinase inhibitors |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/21/2010 | CN101696221A Substituted isoxazoles as fungicides |
| 04/21/2010 | CN101696193A 2-substituted methyl-3-phenyl-acrylic ester compounds with fungicidal activities and preparation method thereof |
| 04/21/2010 | CN101696192A Pyrimidine substituted acrylic ester compounds with fungicidal activities and preparation method thereof |
| 04/21/2010 | CN101696188A Trifluoromethyl substituted benzamides as kinase inhibitors |
| 04/20/2010 | US7700808 1-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 04/20/2010 | US7700771 antiinflammatory agents; antiarthritic agents |
| 04/20/2010 | US7700768 such as 7-Methylsulfanyl-5-phenyl-1-(1-phenylethyl)-3,4-dihydro-1H -pyrimido[4,5-d]pyrimidin-2-one; p38 map kinase inhibitors |
| 04/20/2010 | US7700622 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents |
| 04/20/2010 | US7700609 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune disease; viricides |
| 04/20/2010 | US7700608 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/20/2010 | US7700605 2-cyano-pyrimidines and-triazines as cysteine protease inhibitors |
| 04/20/2010 | US7700604 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 04/20/2010 | US7700603 Use in treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, inhibitors of Human Immunodeficiency Virus, plasmepsins, cathepsin D and protozoal enzymes; 5-(3-(3-trifluoromethoxyphenyl)phenyl)-2,5-dimethyl-1,2,4-oxadiazinan-3-imine, for example |
| 04/20/2010 | US7700588 Pharmaceutical compositions comprising midazolam in a high concentration |
| 04/20/2010 | US7700522 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 04/20/2010 | CA2594017C Preparation of rosuvastatin |
| 04/20/2010 | CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives |
| 04/20/2010 | CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/15/2010 | WO2010042489A2 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010040826A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 04/15/2010 | WO2010040212A1 Processes for the preparation of erlotinib hydrochloride |
| 04/15/2010 | WO2009113704A3 Fluorine-containing compound and method for detecting biomolecule using the same |
| 04/15/2010 | WO2009030467A8 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 04/15/2010 | US20100094004 Process for Preparation of Erlotinib and its Pharmaceutically Acceptable Salts |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093772 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/15/2010 | US20100093758 Pyridine sulfonamide modulators of endothelin-a receptor |
| 04/15/2010 | US20100093746 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of cns diseases |
| 04/14/2010 | EP2173724A2 Quinazolinone compounds and methods of use thereof |
| 04/14/2010 | EP2173723A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 04/14/2010 | EP2173722A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 04/14/2010 | EP2173716A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1633727B1 Improved production of the rosuvastatin calcium salt |
| 04/14/2010 | EP1507533B1 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | CN101693709A Bicyclic amides as kinase inhibitors |
| 04/14/2010 | CN101693697A Pyrizdazine derivatives and their use as therapeutic agents |
| 04/14/2010 | CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 04/14/2010 | CN101182310B Method for preparing biphenyl substituted pyrimidine compounds |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696217 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 04/13/2010 | US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives |
| 04/13/2010 | US7696215 N-isoxazol-3-yl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease or psoriasis |
| 04/13/2010 | US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 04/13/2010 | US7696204 Pharmaceutical compounds |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2345809C 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/08/2010 | WO2010038953A2 Uracil-based compounds, and herbicides comprising same |